APA

Zippelius A., Gati A., Bartnick T., Walton S., Odermatt B., Jaeger E., Dummer R., Urosevic M., Filonenko V., Osanai K., Moch H., Chen Y., Old L. J., Knuth A. & Jaeger D. (20070213). Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients. : Cancer immunology, immunotherapy : CII.

Chicago

Zippelius Alfred, Gati Asma, Bartnick Tammo, Walton Senta, Odermatt Bernhard, Jaeger Elke, Dummer Reinhold, Urosevic Mirjana, Filonenko Valeriy, Osanai Kazuhiro, Moch Holger, Chen Yao-Tseng, Old Lloyd J, Knuth Alexander and Jaeger Dirk. 20070213. Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients. : Cancer immunology, immunotherapy : CII.

Harvard

Zippelius A., Gati A., Bartnick T., Walton S., Odermatt B., Jaeger E., Dummer R., Urosevic M., Filonenko V., Osanai K., Moch H., Chen Y., Old L. J., Knuth A. and Jaeger D. (20070213). Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients. : Cancer immunology, immunotherapy : CII.

MLA

Zippelius Alfred, Gati Asma, Bartnick Tammo, Walton Senta, Odermatt Bernhard, Jaeger Elke, Dummer Reinhold, Urosevic Mirjana, Filonenko Valeriy, Osanai Kazuhiro, Moch Holger, Chen Yao-Tseng, Old Lloyd J, Knuth Alexander and Jaeger Dirk. Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients. : Cancer immunology, immunotherapy : CII. 20070213.